Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
12 2020
Historique:
received: 01 02 2020
revised: 16 05 2020
accepted: 23 05 2020
pubmed: 9 6 2020
medline: 26 10 2021
entrez: 8 6 2020
Statut: ppublish

Résumé

To describe the lesions detected by prenatal ultrasound examination in congenital toxoplasmosis (CT). We retrospectively analyzed all cases of fetal infection with Toxoplasma gondii with ultrasound anomalies described by fetal medicine experts in 2009 to 2019 in 30 French centers. Eighty-eight cases of CT were included. Forty-five (51.1%) had one or more cerebral signs only, 35 (39.8%) had cerebral plus extracerebral signs and 8 (9.1%) had extracerebral signs only. The main cerebral signs were intracranial hyperechogenic nodular foci (n = 60) of which 20 were isolated, ventriculomegalies (n = 44) which generally increased during follow-up, and periventricular abscesses (n = 12). The main extracerebral signs were hepatomegaly and/or splenomegaly (n = 14), small for gestational age (n = 14), ascites (n = 14, including 2 with hydrops), and hyperechogenic bowel (n = 11). Maternal infection occurred mostly in the first or second trimester (81 cases), periconceptionally in one and in the third trimester in six cases. The first ultrasound signs were detected after a median of 7 weeks (range: 1.4; 24.0) following maternal toxoplasmosis seroconversion. While no sign was specific of CT, there were typical associations of cerebral signs with or without extracerebral signs. Detailed ultrasound examination could improve prognostic evaluation, as well as diagnosis of CT in settings lacking serological screening.

Identifiants

pubmed: 32506432
doi: 10.1002/pd.5756
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1741-1752

Informations de copyright

© 2020 John Wiley & Sons, Ltd.

Références

Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369:115-122.
Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J. 2008;27:27-32.
Freeman K, Tan HK, Prusa A, et al. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. 2008;121:e1215-e1222.
Haute Autorité de Santé - Surveillance sérologique et prévention de la toxoplasmose et de la rubéole au cours de la grossesse et dépistage prénatal de
CNR Toxoplasmose - Centre National de Référence sur la Toxoplasmose - CHU de Reims [Internet]. Cited September 3, 2019. http://cnrtoxoplasmose.chu-reims.fr/
Robert-Gangneux F, Darde M-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264-296.
Hohlfeld P, MacAleese J, Capella-Pavlovski M, et al. Fetal toxoplasmosis: ultrasonographic signs: toxoplasmosis: ultrasound. Ultrasound Obstet Gynecol. 1991;1:241-244.
Malinger G, Werner H, Rodriguez Leonel JC, et al. Prenatal brain imaging in congenital toxoplasmosis. Prenat Diagn. 2011;31:881-886.
Dhombres F, Friszer S, Maurice P, et al. Prognosis of fetal parenchymal cerebral lesions without ventriculomegaly in congenital toxoplasmosis infection. Fetal Diagn Ther. 2017;41:8-14.
PLM-toxo-CAT-janvier2017.pdf [Internet]. Cited October 7, 2019. http://www.societe-francaise-neonatalogie.fr/wp-content/uploads/2017/01/PLM-toxo-CAT-janvier2017.pdf#page=1&zoom=auto,-13,842
Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994;331:695-699.
Diagnostic biologique de la toxoplasmose acquise du sujet immunocompétent (dont la femme enceinte), la toxoplasmose congénitale (diagnostic pré- et postnatal) et la toxoplasmose oculaire [Internet]. Haute Autorité de Santé. Cited September 29, 2019. https://www.has-sante.fr/jcms/c_2653655/fr/diagnostic-biologique-de-la-toxoplasmose-acquise-du-sujet-immunocompetent-dont-la-femme-enceinte-la-toxoplasmose-congenitale-diagnostic-pre-et-postnatal-et-la-toxoplasmose-oculaire
Mandelbrot L, Kieffer F, Sitta R, et al. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. 2018;219:386.e1-386.e9.
Peyron F, L'ollivier C, Mandelbrot L, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8:24.
Guibaud L. Fetal cerebral ventricular measurement and ventriculomegaly: time for procedure standardization. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2009;34:127-130.
Hata T, Aoki S, Takamori H, Hata K, Murao F, Kitao M. Ultrasonographic in utero identification and measurement of the normal fetal spleen. Gynecol Obstet Invest. 1987;23:124-128.
Vintzileos AM, Neckles S, Campbell WA, Andreoli JW, Kaplan BM, Nochimson DJ. Fetal liver ultrasound measurements during normal pregnancy. Obstet Gynecol. 1985;66:477-480.
Strocker AM, Snijders RJ, Carlson DE, et al. Fetal echogenic bowel: parameters to be considered in differential diagnosis: prognosis of echogenic fetal bowel. Ultrasound Obstet Gynecol. 2000;16:519-523.
Lee AJ, Bethune M, Hiscock RJ. Placental thickness in the second trimester: a pilot study to determine the normal range. J Ultrasound Med Off J Am Inst Ultrasound Med. 2012;31:213-218.
Hedlund GL, Boyer RS. Neuroimaging of postnatal pediatric central nervous system infections. Semin Pediatr Neurol. 1999;6:299-317.
Massoud M, Duyme M, Fontanges M. French College of Fetal Sonography (CFEF), Combourieu D. [Chart for estimation of fetal weight 2014 by the French College of Fetal Sonography (CFEF)]. J Gynecol Obstet Biol Reprod (Paris). 2016;45:80-85.
Blondiaux E, Garel C. Fetal cerebral imaging - ultrasound vs. MRI: an update. Acta Radiol. 2013;54:1046-1054.
Fallahi S, Rostami A, Nourollahpour Shiadeh M, Behniafar H, Paktinat S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J Gynecol Obstet Hum Reprod. 2018;47:133-140.
Hutson SL, Wheeler KM, McLone D, et al. Patterns of hydrocephalus caused by congenital Toxoplasma gondii infection associate with parasite genetics. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61:1831-1834.
Abboud P, Harika G, Saniez D, et al. Ultrasonic signs of fetal toxoplasmosis. Review of the literature. J Gynecol Obstet Biol Reprod (Paris). 1995;24:733-738.
Carme B, Demar-Pierre M. Toxoplasmosis in French Guiana. Atypical (neo-)tropical features of a cosmopolitan parasitosis. Med Trop Rev Corps Sante Colon. 2006;66:495-503.
Carme B, Demar M, Ajzenberg D, Dardé ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii. French Guiana Emerg Infect Dis. 2009;15:656-658.
Delhaes L, Ajzenberg D, Sicot B, et al. Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review. Prenat Diagn. 2010;30:902-905.
Malinger G, Lev D, Zahalka N, et al. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. Am J Neuroradiol. 2003;24:28-32.
Pires P, Jungmann P, Galvão JM, et al. Neuroimaging findings associated with congenital Zika virus syndrome: case series at the time of first epidemic outbreak in Pernambuco state. Brazil Childs Nerv Syst. 2018;34:957-963.
Li X-L, Wei H-X, Zhang H, Peng H-J, Lindsay DS. A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PloS One. 2014;9:e97775.

Auteurs

Camille Codaccioni (C)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, APHP Nord Université de Paris, Colombes, France.
Inserm, IAME, Université de Paris, Paris, France.

Olivier Picone (O)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, APHP Nord Université de Paris, Colombes, France.
Inserm, IAME, Université de Paris, Paris, France.

Véronique Lambert (V)

Service de Gynécologie-Obstétrique, Centre Hospitalier de l'Ouest Guyanais, St Laurent du Maroni, France.

Paul Maurice (P)

Assistance Publique-Hôpitaux de Paris, Service de Médecine Foetale, Hôpital Trousseau, APHP Sorbonne, Paris, France.

Léo Pomar (L)

Service de Gynécologie-Obstétrique, Centre Hospitalier de l'Ouest Guyanais, St Laurent du Maroni, France.

Norbert Winer (N)

Centre Hospitalier Universitaire de Nantes, Service de Gynécologie-Obstétrique, NUN, INRA, UMR 1280, Phan, Université de Nantes, Nantes, France.

Laurent Guibaud (L)

Centre Hospitalier Universitaire de Nantes, Laboratoire Parasitologie et Mycologie, and NUN, INRA, UMR 1280, Phan, Université de Nantes, Nantes, France.

Rose-Anne Lavergne (RA)

Service de Radiologie, Centre Hospitalier Universitaire de Lyon, Lyon, France.

Anne-Hélène Saliou (AH)

Service de Gynécologie-Obstétrique, Centre Hospitalier Régional et Universitaire de Brest, Brest, France.

Dorothée Quinio (D)

Laboratoire Parasitologie et Mycologie, Centre Hospitalier Régional et Universitaire de Brest, Brest, France.

Alexandra Benachi (A)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, Université Paris-Saclay, Clamart, France.

Catherine Noel (C)

Service de Gynécologie-Obstétrique, Centre Hospitalier René Dubos, Pontoise, France.

Yves Ville (Y)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Necker Enfants Malades APHP Centre Université de Paris, Paris, France.

Fabrice Cuillier (F)

Service de Gynécologie-Obstétrique, Centre Hospitalier Régional Félix Guyon, Saint-Denis, Réunion, France.

Christelle Pomares (C)

Centre Hospitalier Universitaire de Nice, Service de Parasitologie-Mycologie, C3M INSERM 1065, Université Côte d'Azur, Nice, France.

Nicole Ferret (N)

Centre Hospitalier Universitaire de Nice, Service de Pédiatrie, Université Côte d'Azur, Nice, France.

Denis Filisetti (D)

Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.

Anne-Sophie Weingertner (AS)

Service de Gynécologie-Obstétrique, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.

Valérie Vequeau-Goua (V)

Service de Gynécologie-Obstétrique, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.

Estelle Cateau (E)

Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.

Guillaume Benoist (G)

Service de Gynécologie-Obstétrique, Centre Hospitalier Universitaire de Caen, Caen, France.

Martine Wallon (M)

Service de Parasitologie-Mycologie, Centre Hospitalier Universitaire de Lyon, Lyon, France.

Marc Dommergues (M)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital de la Pité-Salpêtrière, APHP Sorbonne, Paris, France.

Isabelle Villena (I)

Centre National de Référence de la Toxoplasmose, Centre de Ressources Biologiques Toxoplasma, Service de Parasitologie-Mycologie, EA 7510, UFR Médecine, Centre Hospitalier Universitaire de Reims, Reims, France.

Laurent Mandelbrot (L)

Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, APHP Nord Université de Paris, Colombes, France.
Inserm, IAME, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH